The PRESIDE trial: A randomized, double-blind, placebo-controlled phase III efficacy and safety study of continued enzalutamide plus docetaxel after disease progression on enzalutamide alone in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback